Sun Pharma Board Approves Fundraising of Up to ₹10,000 Crore via NCDs
Sun Pharmaceutical Industries said its board approved a proposal to raise up to ₹10,000 crore through non-convertible debentures at an October 12 meeting.
The decision was taken at a meeting of the company's Board of Directors held on October 12, Sun Pharma said in a regu…